In addition to a multi-disciplinary Asthma Center, our institution also has a “modified Asthma Center” (MAC) for patients with less severe asthma referred by their primary care physician. The MAC involves intensive patient education by a trained pharmacist (LM). We measured quality of life outcomes at baseline, one month and six months to determine whether patients showed improvement.
Referred patients who did not have difficult-to-control asthma were seen in the MAC. Intervention by the pharmacist included intensive asthma education. Any recommended changes in the patients’ medical regimens were discussed with and approved by a supervising physician. We assessed patients using the Asthma Quality of Life Questionnaire (AQLQ) and classified the severity of their asthma using the 1997 NAEP guidelines: mild intermittent (1), mild persistent (2), moderate persistent (3) and severe persistent (4). Other measures included inhaled corticosteroid (ICS) use, compliance with medication and the use of an action plan. Data were collected before or during the first visit, after one month and after six months.
AQLQ scores and NAEP severity of asthma classification scores are summarized in the attached tableBaselineOne monthSix monthsAQLQ score (1-7) (mean, range)4.4 (1.9-6.5) n=655.4 (2.1-7.0) n=435.6 (2.9-7.0) n=22BaselineOne monthSix monthsNHLBI Classification (1-4) (mean)2.8 n=632.2 n=242.1 n=10Asthma symptoms (1-4) (mean)2.5 n=701.8 n=451.6 n=21Rescue medication use (1-4) (mean)2.4 n=631.6 n=221.4 n=9Peak flow (1-4) (mean)2.1 n=482.3 n=151.8 n=5. The overall AQLQ score improved from 4.4 to 5.4 at one month and 5.6 at six months. The overall NAEP classification improved from 2.8 to 2.2 at one month and 2.1 at six months. Patients using ICS increased from 66% at baseline to 80% at one month and 91% at six months. 83% were found to be compliant with their medications at baseline, compared to 75% at one month and 100% at six months. No patients used an action plan at baseline, compared to 95% at one month and 100% at six months.
Patients with mild to moderate persistent asthma who underwent asthma education in our MAC showed improvement over six months in AQLQ scores, severity of asthma, use of ICS and compliance with their medical regimen.
Asthma education by a trained pharmacist results in improved quality of life of patients with asthma.
L. Mitchell, None.